Can a church walking group help older adults stay active?
NCT ID NCT07340099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study partners with 26 AME churches in South Carolina to test a 32-week walking program called Walk Your Heart to Health. About 300 adults aged 50 and older will join in-person walking groups led by church committees. Researchers will measure changes in daily steps and group cohesion, and identify what helps or hinders putting the program into practice.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Walk Your Heart to Health (32-week walking program delivered by church committees)
- What this could lead to
- If successful, this could provide a proven, scalable way for churches to help older adults become more active and reduce chronic disease risk.
- What could go wrong
- This is an early-stage implementation study, not a clinical trial of a drug. Results depend on church participation and may not apply to other settings. The program may not produce lasting changes in physical activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Member of participating church (Charleston or Columbia Districts of the 7th Episcopal District of the AME church) or is in larger neighborhood and able to attend * Aged 50 years and older * Agrees to participate in in-person walking group sessions * Not planning to move in the next year from a location that would make study visits difficult Exclusion Criteria: * No contraindications to exercise, as determined by the PAR-Q
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic disease prevention are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of South Carolina
Columbia, South Carolina, 29208, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body